
Test detects breast cancer in earliest stage
The new research results were presented at the 2019 NCRI Cancer Conference today by Daniyah Alfattani from National Cancer Research Institute (NCRI)...

bit bio restarts with new management
Cambridge-based cell reprogramming specialist Elpis Biomed will be re-started under the new name bit bio with a new management and an extended...

€7.34m for cancer vaccine developer
Private clinical-stage biotech MaxiVAX announced that it has been awarded a European Commission grant of €2,785,000, thanks to the Horizon 2020 EIC...

Evotec and Celmatix enter strategic partnership
Under the terms of the strategic R&D collaboration, Celmatix Inc. (New York) will utilise its proprietary multi-omics Reproductive Atlas platform...

Pharvaris BV raises $66m to advance oral HAE drug
The Series B financing was led by Foresite Capital. New investors Bain Capital Life Sciences, venBio and Venrock, as well as the investors of a €15m...

Big Pharma is cost driver of GAVI
MSF demanded the GAVI to immediately stop paying out funds from a remaining US$262m subsidy to Pfizer and GlaxoSmithKline (GSK) for the pneumococcal...

Researchers unravel how ADEP antibiotics work
Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...